Darren Klein

Equibles does not estimate personal net worth.

Get an email with a short summary when Xenon Pharmaceuticals Inc. publishes a filing, an earnings call transcript or a press release.

Get XENE alerts

About Darren Klein

Darren Klein has spoken on 1 earnings call across 1 company, most recently for Xenon Pharmaceuticals Inc. on November 9, 2026. Xenon Pharmaceuticals Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Xenon Pharmaceuticals Inc. includes Ian Mortimer (CEO, Chief Accounting Officer and Board Member), Simon Pimstone (Chairman), Thomas (Tucker) Kelly (CFO) and 7 others.

Darren Klein on recent calls

“It's been a busy and exciting few months for our team as we continue to make meaningful progress across three commercial priorities.”

Other, Q3 2026 Xenon Pharmaceuticals Inc. Earnings Conference Call · November 9, 2026

Affiliation history

Xenon Pharmaceuticals Inc. (XENE)
Transcript header (unverified)

Current

Company network

Xenon Pharmaceuticals Inc.

XENE

Current role

Biotechnology · Healthcare

1 appearance Latest appearance 2026-11-09

View calls and events

Leadership on record at Xenon Pharmaceuticals Inc.

Ian Mortimer CEO, Chief Accounting Officer, Board Member
Simon Pimstone Chairman
Thomas (Tucker) Kelly CFO
Thomas Kelly CFO
Tucker Kelly CFO
Clarissa Desjardins Board Member
Dawn Svoronos Board Member
Dr. Clarissa Desjardins Board Member
Dr. Gillian Cannon Board Member
Elizabeth Garofalo Board Member

Recent activity

Earnings call Q3 2026 Xenon Pharmaceuticals Inc. Earnings Conference Call Xenon Pharmaceuticals Inc. (XENE)
2026-11-09